alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Martin CARRIZALES, Appellant, v. STATE of Florida, Appellee.

No. 76-236.

District Court of Appeal of Florida, Second District.

March 31, 1978.

Jack 0. Johnson, Public Defender, Bar-tow and Douglas A. Wallace, Asst. Public Defender, Bradenton, for appellant.

Robert L. Shevin, Atty. Gen., Tallahassee, and C. Marie King, Asst. Atty. Gen., Tampa, for appellee.

PER CURIAM.

WHEREAS the decision of this court (345 So.2d 1113) was entered on May 20, 1977, reversing the judgment of the circuit court of Hardee County, Florida, and awarding appellant a new trial on grounds the trial court erred in refusing to give the jury an instruction requested by appellant; and

WHEREAS the Supreme Court of Florida by its opinion and judgment filed February 23, 1978 (Case No. 51,788), 356 So.2d 274, and mandate now lodged in this court quashed this court’s judgment and remanded this cause to this court for consideration of appellant’s remaining points on appeal; and

WHEREAS this court has now considered the additional points raised on appeal by appellant and has found the same to be without merit.

NOW, THEREFORE, It is Ordered:

1. The opinion of this court issued in this cause on May 20, 1977 and reported at 345 So.2d 1113 is hereby withdrawn, as is the mandate issued pursuant thereto.

2. The opinion and judgment of the Supreme Court of Florida filed February 23, 1978 (Case No. 51,788), is hereby made the opinion and judgment of this court as supplemented by this opinion in which we find *448no merit in the additional points on appeal raised by appellant.

3. The judgment and sentence of the trial court appealed herein is hereby affirmed.

BOARDMAN, C. J., and GRIMES and SCHEB, JJ., concur.
Exhibit 21

Subsidiaries of the Registrant

(All are Delaware entities unless otherwise indicated)



|                                               |  | 
|---------------------------------------------- |  | 
|US Oncology Specialty, LP                      |  | 
|US Oncology Corporate, Inc.                    |  | 
|US Oncology Pharmaceutical Services, LLC       |  | 
|US Oncology Pharmacy GPO, L.P.                 |  | 
|US Oncology Research, Inc. (1)                 |  | 
|Alabama Pharmaceutical Services, LLC           |  | 
|AOR Holding Company of Indiana, Inc.           |  | 
|AOR Management Company of Arizona, Inc.        |  | 
|AOR Management Company of Indiana, Inc.        |  | 
|AOR Management Company of Missouri, Inc.       |  | 
|AOR Management Company of Oklahoma, Inc.       |  | 
|AOR Management Company of Pennsylvania, Inc.   |  | 
|AOR Management Company of Texas, Inc.          |  | 
|AOR Management Company of Virginia, Inc.       |  | 
|AOR of Texas Management Ltd. Partnership (1)   |  | 
|AOR Real Estate of Greenville LP               |  | 
|AOR Real Estate, Inc.                          |  | 
|AOR Synthetic Real Estate, Inc.                |  | 
|AORT Holding Company, Inc.                     |  | 
|California Pharmaceutical Services, LLC        |  | 
|Carrol County Cancer Center, Ltd. (3)          |  | 
|Colorado Cancer Centers, L.L.C.                |  | 
|East Indy CC, LLC (2)                          |  | 
|Florida Pharmaceutical Services, LLC           |  | 
|Greenville Radiation Care, Inc.                |  | 
|Iowa Pharmaceutical Services, LLC              |  | 
|KCCC JV, LLC                                   |  | 
|Michigan Pharmaceutical Services, LLC          |  | 
|Nebraska Pharmaceutical Services, LLC          |  | 
|New Mexico Pharmaceutical Services, LLC        |  | 
|North Carolina Pharmaceutical Services, LLC    |  | 
|Oregon Cancer Center, Ltd. (4)                 |  | 
|Pennsylvania Pharmaceutical Services, LLC      |  | 
|Physician Reliance Holdings, LLC               |  | 
|Physician Reliance Network, Inc.               |  | 
|Physician Reliance, L.P. (1)                   |  | 
|PRN Physician Reliance, LLC                    |  | 
|RMCC Cancer Center, Inc.                       |  | 
|SelectPlus Oncology, LLC d/b/a SelectPlus, LLC |  | 
|Southeast Texas Cancer Centers, L.P. (1)       |  | 
|St. Louis Pharmaceutical Services, LLC         |  | 
|Texas Pharmaceutical Services, LLC             |  | 
|TOPS Pharmacy Services, Inc. (1)               |  | 
|Washington Pharmaceutical Services, LLC        |  | 



|(1) | Organized in the State of Texas
|--- | -------------------------------

|(2) | Organized in the State of Indiana
|--- | ---------------------------------

|(3) | Organized in the State of Maryland
|--- | ----------------------------------

|(4) | Organized in the State of Oregon
|--- | --------------------------------
EXHIBIT 32



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report of American Unity Investments, Inc. ("Company") on Form  10-QSB  for the  period  ending September 30, 2007 as filed  with the Commission on the date hereof, I, Christian Lillieroos, chief operating officer of the Company,  certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:



(1) This 10-QSB complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange Act; and



(2) The financial  information contained in this Form 10-QSB fairly presents, in all material respects,  the financial  condition and result of operations of the Company.





By:  /s/Christian Lillieroos

Chief Operating Officer

(principal executive, accounting and financial  officer)

November 13, 2007
# L_2023239EN.01003901.xml

| 28.9.2023 | EN | Official Journal of the European Union | L 239/39 |
| --- | --- | --- | --- |

28.9.2023

EN

Official Journal of the European Union

L 239/39

---

Corrigendum to Commission Regulation (EU) 2023/1803 of 13 August 2023 adopting certain international accounting standards in accordance with Regulation (EC) No 1606/2002 of the European Parliament and of the Council

(
  Official Journal of the European Union L 237 of 26 September 2023
  )

On page 1, in the title, and on page 3, in the concluding formula:

for:

‘
  13 August 2023
  ’,

read:

‘
  13 September 2023
  ’.

---
EXHIBIT 31(a) 

 

**Certification of Chief Executive Officer**

**Pursuant to Rule 13a-14(a)/15d-14(a)**

 

I,Greg L. McKee, President and Chief Executive Officer, certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Citizens Holding Company; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over thefinancial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

 

a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

b. evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

c. disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materiallyaffect, the registrant’s internal control over financial reporting; and 

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s 

auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

a. all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b. any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control over financial reporting. 

 
  
Date: November 12, 2003
  
                /s/ Greg L. McKee
  
Greg L. McKee
  
President and Chief Executive Officer
II 

109TH CONGRESS 

1ST SESSION S. 1667 

To suspend temporarily the duty on Baypure CX. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 12, 2005 

Mr. SANTORUM introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL

To suspend temporarily the duty on Baypure CX.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SUSPENSION ON DUTY ON BAYPURE CX. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading:

‘‘ 9902.39.14 Iminodisuccinic Acid, 

Triammonium Salt, in Aqueous Solutions (CAS No. 

415719–09–04) (provided 

for in subheading 

2922.49.80) ......................... Free No change No change On or before 

12/31/2009 ’’. 
2

•S 1667 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act.

Æ
#### Ida Lee EVETT, Petitioner, v. CITY OF INVERNESS, a municipal corporation, Respondent.

No. 38885.

Supreme Court of Florida.

Feb. 25, 1970.

Ray Graham, Sarasota, for petitioner.

Lucuis M. Dyal, Jr., of Shackelford, Far-rior, Stallings & Evans, Tampa, for respondent.

Wm. Reece Smith, Jr., and Daniel R. Walbolt, Tampa, amici curiae.

PER CURIAM.

The petition for writ of certiorari reflected probable jurisdiction in this Court. We issued the writ and have heard argument of the parties. After argument and upon further consideration of the matter, we have determined that the writ was improvidently issued. Therefore, the writ is hereby discharged and the petition for writ of certiorari is dismissed.

ERVIN, C. J., and ROBERTS, CARLTON, ADKINS and BOYD, JJ., concur.
Exhibit 32.2

Beacon Enterprise Solutions Group, Inc.CERTIFICATION OF PERIODIC REPORTPursuant to Section 906 of the Sarbanes-Oxley Act of 200218 U.S.C. Section 1350

The undersigned executive officer of Beacon Enterprise Solutions Group, Inc. (the “Company”) certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

-  the quarterly report on Form 10-Q of the Company for the quarter ended June 30, 2009, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 
- the information contained in the Form 10-Q fairlypresents, in all material respects, the financial condition and results of operations of the Company.

|                       |                             |
|-----------------------|-----------------------------|
| Date: August 12, 2009 | /s/ Robert R. Mohr          |
|                  |                             |
|                  | Robert R. Mohr              |
|                  | Principal Financial Officer |

47

----
```

[Federal Register Volume 78, Number 96 (Friday, May 17, 2013)]
[Notices]
[Pages 29200-29201]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11875]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 8324]

In the Matter of the Designation of Abu Muhammad al-Jawlani Also 
Known as al-Fatih Also Known as Abu Muhammad al-Golani as a Specially 
Designated Global Terrorist Pursuant to Section 1(b) of Executive Order 
13224, as Amended

    Acting under the authority of and in accordance with section 1(b) 
of Executive Order 13224 of September 23, 2001, as amended by Executive 
Order 13268 of July 2, 2002, and Executive Order 13284 of January 23, 
2003, I hereby determine that the individual known as Abu Muhammd al-
Jawlani, also known al-Fatih, also known as Abu Muhammad al-Golani, 
committed, or poses a significant risk of committing, acts of terrorism 
that threaten the security of U.S. nationals or the national

[[Page 29201]]

security, foreign policy, or economy of the United States.
    Consistent with the determination in Section 10 of Executive Order 
13224 that ``prior notice to persons determined to be subject to the 
Order who might have a constitutional presence in the United States 
would render ineffectual the blocking and other measures authorized in 
the Order because of the ability to transfer funds instantaneously,'' I 
determine that no prior notice needs to be provided to any person 
subject to this determination who might have a constitutional presence 
in the United States, because to do so would render ineffectual the 
measures authorized in the Order.
    This notice shall be published in the Federal Register.

    Dated: April 16, 2013.
John F. Kerry,
Secretary of State.
[FR Doc. 2013-11875 Filed 5-16-13; 8:45 am]
BILLING CODE 4710-10-P
```
[KPMG LLP LETTERHEAD]


                          Independent Auditors' Consent


The Board of Directors
CCF Holding Company

We consent to  incorporation  by reference in the  registration  statement  (No.
333-4194)  on Form S-8 of CCF Holding  Company of our report  dated  February 6,
1998,  relating to the  consolidated  balance  sheet of CCF Holding  Company and
subsidiary  as of December 31, 1997 and the related  consolidated  statements of
earnings,  comprehensive  income,  stockholders'  equity  and cash flows for the
years ended  December 31, 1997 and September 30, 1996,  and for the  three-month
period ended  December 31, 1996,  which report  appears in the December 31, 1998
annual report on Form 10-KSB of CCF Holding Company.

------------
/s/ KPMG LLP     
    KPMG LLP


Atlanta, Georgia
March 26, 1999
~ 0.00 > ),tH ~ 0 .Oil 

s 0.00 ~- 1)1)(\ \ 0.011 

s 0.00 .., t ~ pn (i• 0. 1

Hl 

The known number of products in compliance: Number 

Total Costs of compliance for U.S. fleet: $415,650 

Costs covered under warranty (if known) $Warranty 

On-Condition Costs: · 

Action Work-hours Labor cost Parts Cost Cost per Product 

(e.g., Inspection, (include access, (@$85/hour) 

replacement) testing, and closeup) 

$ 0.00 'S OJliJ 

$ 0.00 ' li.Ot• 

s 0.00 ':.> p no 

' !).0() I iii, 

Special considerations for Economic Analysis (Use this field to explain anything in the Estimated Costs table 

that was assumed or might not be obvious. This field can also be used to explain warranty costs): 

Repair costs are not specified by Boeing. Materials are listed in SB on pages 38-41 but since patches and 

doublers are manufactured as needed, no cost is identified. 

There are two optional terminating actions. 

Ia) PART3: Groups 1&2 ZONE 1- PREVENTIVE MODIFICATION= 144 work hours (SB pg 29-30) 

lb) PART3: Group 3 ZONE 1- PREVENTIVE MODIFICATION= 139 work hours (SB pg 30-31) 

2a) Groups 1&2 SKIN PANEL REPLACEMENT= 615 work hours (SB page 33) 

2b) Group 3 SKIN PANEL REPLACEMENT= 573 work hours (SB page 33) 

2c) Skin panel cost from $20,3 16 to $26,496 (SB page 3 7) 

This is a partial list of all the hours and costs associated with the actions in SB 757-53 -0097 rev 2. See 

Section G. Manpower (pages 28- 33) 

Executive Order 12866: 

Could the AD be considered a "significant regulatory action"? · 

YES* D NO lZI 

*Explanation: 

DOT Regulatory Policies and Procedures: 

Is the AD significant? • 

YES* D NO lZI 

*Explanation: 

Regulatory Flexibility Act: 

Will the AD have a significant economic impact on a substantial number of small entities? Explain for 

either a Yes or No answer. ~ 

YES D NO lZI 

9 
Explanation: 

Intrastate Aviation in Alaska: 

This AD could affect intrastate aviation in Alaska. Is it appropriate to include specific requirements for 

aircraft operated in Alaska where aviation might be the only mode of transportation? • 

YES* 0 NO~ 

*Explanation: 

10
Electronically Filed

Intermediate Court of Appeals

CAAP-10-0000181

26-FEB-2016

08:47 AM
Exhibit 32.1








CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of TREATY ENERGY CORPORATION (the "Company") on Form 10-Q as filed with the Securities and Exchange Commission on the date hereof (the "Report'), I, Andrew V. Reid, Chief Executive Officer of the Company, certify, pursuant to 18 USC section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.







Date: May 16, 2011
By:
/s/ Andrew V. ReidAndrew V. ReidChief Executive Officer
### -79 -78 -77 -76 -75 38 39 

## ★ ▲ ▲ ▲ ▲



## ★ ▲ ▲ ▲ ▲ 

### 500 1000 1500 100 18 12 06 00 07/19 

## NOAA HYSPLIT MODEL 

# Backward trajectory ending at 2300 UTC 19 Jul 06

EDAS Meteorological DataSource★at 38.48 N 77.37 WMeters AGL 

## ★ ■ ■ ■ ■



## ★ ■ ■ ■ ■



## ★ ● ● ●



## ★ ● ● ● ●
<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED>
<CIK> 0000723610
<NAME> STRATUS COMPUTER, INC.
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-28-1997
<PERIOD-START>                             DEC-30-1996
<PERIOD-END>                               MAR-30-1997
<CASH>                                          145640
<SECURITIES>                                     37552
<RECEIVABLES>                                   145440
<ALLOWANCES>                                      8534
<INVENTORY>                                      86029
<CURRENT-ASSETS>                                440281
<PP&E>                                          359041
<DEPRECIATION>                                  237080
<TOTAL-ASSETS>                                  635046
<CURRENT-LIABILITIES>                           117616
<BONDS>                                           1970
<COMMON>                                           265
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      537731
<TOTAL-LIABILITY-AND-EQUITY>                    635046
<SALES>                                         106527
<TOTAL-REVENUES>                                155665
<CGS>                                            56309
<TOTAL-COSTS>                                   109772
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              (2460)
<INCOME-PRETAX>                                  18946
<INCOME-TAX>                                      4168
<INCOME-CONTINUING>                              14778
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     14778
<EPS-PRIMARY>                                      .64
<EPS-DILUTED>                                      .62



</TABLE>
* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion

should not be published and is not precedent except under the limited

circumstances set forth in 5TH CIR. R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-61167

Summary Calendar

TUAN CHAU PHAM

Petitioner

v.

MICHAEL B MUKASEY, U S ATTORNEY GENERAL

Respondent

Petition for Review of an Order of the

Board of Immigration Appeals

BIA No. A37 341 363

Before KING, DENNIS, and OWEN, Circuit Judges.

PER CURIAM:*

Tuan Chau Pham is a native and citizen of Vietnam who was ordered

deported from this country based on a determination that he had committed

aggravated felonies that were crimes of violence. Pham moved to reopen his case

and argued that he was eligible for relief under former 8 U.S.C. § 1182(c). The

immigration judge denied both Pham’s motion to reopen and his subsequent

motion for reconsideration, and the Board of Immigration Appeals (BIA)

affirmed the immigration judge. Pham now petitions this court for review.

United States Court of Appeals

Fifth Circuit

F I L E D

October 21, 2008

Charles R. Fulbruge III

Clerk
No. 05-61167

2

Pham will receive relief only if he shows thatthe BIA abused its discretion when

it affirmed the denial of his motion. See Singh v. Gonzales, 436 F.3d 484, 487

(5th Cir. 2006).

Pham argues that the BIA’s application of former § 1182(c) is contrary to

INS v. St. Cyr, 533 U.S. 289, 295 (2001), and violative of his equal protection

rights. These arguments are unavailing. See Brieva-Perez v. Gonzales, 482 F.3d

356, 359 (5th Cir. 2007); Vo v. Gonzales, 482 F.3d 363, 366-70 (5th Cir. 2007).

Pham’s petition for review is DENIED.
**EXHIBIT      32.1**

**Certification      Pursuant to 18 U.S.C. Section 1350, As Adopted**

**Pursuant      to Section 906 of The Sarbanes-Oxley Act of 2002**

| (1) | the                Quarterly Report on Form 10-QSB of the Company for the fiscal quarter                ended January 31, 2007 (the “Report”) fully complies with the requirements                of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934                (15                U.S.C. 78m or 78o(d)); and |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | the                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated:              March 14,              2007 |                                        |          |
|-------------------------------------------------|---------------------------------------------|---------------|
|                                       |                                   |     |
|                                                 | By:                               | /s/Amos Eiran |
|                                            | Name:              Amos Eiran               |
|                                            | Title: Chief Executive              Officer |

----